| • | Who: | |
| • | Date/Time: | |
| • | Dial-in Information:1-888-334-5785 | |
| • | Conference Link: https://join.broaddata.com/?id=research-frontiers | |
| • | Replay: Available on | |
Third Quarter Financial Results and Key Business Developments
Fee income was
The net loss for the quarter was
At
In October, Gauzy Ltd., a licensee, strategic investor in the Company, and key participant in the SPD manufacturing supply chain, announced new financing and the restructuring of its liabilities. Gauzy has stated that payments from additional financing and capital resources have begun to support the restart of SPD emulsion production in
Management Commentary
“During our August conference call, we discussed the extraordinary disruption caused by the financial situation of Gauzy, a major participant in our supply chain,” said
“What is particularly encouraging is the breadth of the opportunity,” Harary continued. “SPD technology is already proven in demanding automotive, aircraft, marine and architectural applications. We have been selected for electronically dimmable windows on two new North American aircraft models and the recent unveiling of a third new aircraft using our SPD-Smart technology. We are developing black SPD to offer designers additional choices, and our architectural retrofit initiative is aimed at a substantial installed base of existing buildings, rather than only new construction. We also continue to see interest from manufacturers and project developers across our markets. The strong underlying demand for better light and heat control, and the demonstrated performance and reliability of our SPD-Smart light control technology gives us good reason to be enthusiastic about the work ahead.”
During today’s investor conference call, management expects to discuss the Gauzy developments, the status of the SPD supply chain, commercial programs, product development, liquidity and other matters.
For more details, please see the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ending
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology that allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to numerous companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube.
Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.
CONTACT:
Joseph M. Harary
President and CEO
Research Frontiers Inc.
+1-516-364-1902
Info@SmartGlass.com
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Balance Sheets
| (Unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 644,628 | $ | 664,299 | ||||
| Royalties receivable, net of reserves of | 223,853 | 408,666 | ||||||
| Prepaid expenses and other current assets | 114,187 | 70,969 | ||||||
| Total current assets | 982,668 | 1,143,934 | ||||||
| Fixed assets, net | 2,559 | 3,393 | ||||||
| Operating lease ROU assets | 917,308 | 1,048,352 | ||||||
| Deposits and other assets | 56,066 | 56,066 | ||||||
| Total assets | $ | 1,958,601 | $ | 2,251,745 | ||||
| Liabilities and Shareholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Current portion of operating lease liability | $ | 156,511 | $ | 146,043 | ||||
| Accounts payable | 156,474 | 132,666 | ||||||
| Deferred revenue | 27,452 | - | ||||||
| Accrued expenses | 104,166 | 19,168 | ||||||
| Total current liabilities | 444,603 | 297,877 | ||||||
| Operating lease liability, net of current portion | 901,209 | 1,020,242 | ||||||
| Total liabilities | 1,345,812 | 1,318,119 | ||||||
| Shareholders’ equity: | ||||||||
| Common stock, par value | 3,487 | 3,365 | ||||||
| Additional paid-in capital | 129,926,946 | 128,552,068 | ||||||
| Accumulated deficit | (129,317,644 | ) | (127,621,807 | ) | ||||
| Total shareholders’ equity | 612,789 | 933,626 | ||||||
| Total liabilities and shareholders’ equity | $ | 1,958,601 | $ | 2,251,745 | ||||
Condensed Consolidated Statements of Operations
(Unaudited)
| Nine months ended | Three months ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Fee income | $ | 299,706 | $ | 1,049,125 | $ | 77,041 | $ | 359,444 | ||||||||
| Operating expenses | 1,624,186 | 1,934,041 | 475,588 | 521,642 | ||||||||||||
| Research and development | 393,808 | 473,709 | 119,574 | 141,746 | ||||||||||||
| Total expenses | 2,017,994 | 2,407,750 | 595,162 | 663,388 | ||||||||||||
| Operating loss | (1,718,288 | ) | (1,358,625 | ) | (518,121 | ) | (303,944 | ) | ||||||||
| Interest income | 22,451 | 31,247 | 7,817 | 5,436 | ||||||||||||
| Other income | - | 47,357 | - | - | ||||||||||||
| Net loss | $ | (1,695,837 | ) | $ | (1,280,021 | ) | $ | (510,304 | ) | $ | (298,508 | ) | ||||
| Basic and diluted net loss per common share | $ | (0.05 | ) | $ | (0.04 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
| Weighted average number of common shares outstanding | 34,631,755 | 33,648,221 | 34,867,786 | 33,648,221 | ||||||||||||
Condensed Consolidated Statements of Shareholders’ Equity
(Unaudited)
For the nine months ended
| Additional | ||||||||||||||||||||
| Common Stock | Paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
| Balance, | 33,648,221 | $ | 3,365 | $ | 128,177,193 | $ | (125,576,223 | ) | $ | 2,604,335 | ||||||||||
| Share-based compensation | - | - | 175,204 | - | 175,204 | |||||||||||||||
| Net loss | - | - | - | (1,280,021 | ) | (1,280,021 | ) | |||||||||||||
| Balance, | 33,648,221 | $ | 3,365 | $ | 128,352,397 | $ | (126,856,244 | ) | $ | 1,499,518 | ||||||||||
| Balance, | 33,648,221 | $ | 3,365 | $ | 128,552,068 | $ | (127,621,807 | ) | $ | 933,626 | ||||||||||
| Issuance of common stock and warrants | 1,219,565 | 122 | 1,374,878 | - | 1,375,000 | |||||||||||||||
| Net loss | - | - | - | (1,695,837 | ) | (1,695,837 | ) | |||||||||||||
| Balance, | 34,867,786 | $ | 3,487 | $ | 129,926,946 | $ | (129,317,644 | ) | $ | 612,789 | ||||||||||
For the three months ended
| Additional | ||||||||||||||||||||
| Common Stock | Paid-in | Accumulated | ||||||||||||||||||
| Shares | Amount | Capital | Deficit | Total | ||||||||||||||||
| Balance, | 33,648,221 | $ | 3,365 | $ | 128,352,397 | $ | (126,557,736 | ) | $ | 1,798,026 | ||||||||||
| Net loss | - | - | - | (298,508 | ) | (298,508 | ) | |||||||||||||
| Balance, | 33,648,221 | $ | 3,365 | $ | 128,352,397 | $ | (126,856,244 | ) | $ | 1,499,518 | ||||||||||
| Balance, | 34,867,786 | $ | 3,487 | $ | 129,926,946 | $ | (128,807,340 | ) | $ | 1,123,093 | ||||||||||
| Net loss | - | - | - | (510,304 | ) | (510,304 | ) | |||||||||||||
| Balance, | 34,867,786 | $ | 3,487 | $ | 129,926,946 | $ | (129,317,644 | ) | $ | 612,789 | ||||||||||
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| Nine months ended | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (1,695,837 | ) | $ | (1,280,021 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 947 | 9,279 | ||||||
| Share-based compensation | - | 175,204 | ||||||
| Credit loss expense | 169,527 | 124,253 | ||||||
| ROU asset amortization | 131,044 | 130,607 | ||||||
| Change in assets and liabilities: | ||||||||
| Royalty receivables | 15,286 | 162,082 | ||||||
| Prepaid expenses and other assets | (43,218 | ) | (19,114 | ) | ||||
| Accounts payable and accrued expenses | 108,806 | (74,294 | ) | |||||
| Deferred revenue | 27,452 | 5,336 | ||||||
| Operating lease liability | (108,565 | ) | (96,546 | ) | ||||
| Net cash used in operating activities | (1,394,558 | ) | (863,214 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of fixed assets | (113 | ) | (582 | ) | ||||
| Net cash used in investing activities | (113 | ) | (582 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Net proceeds from sale of common stock and warrants | 1,375,000 | - | ||||||
| Net cash provided by financing activities | 1,375,000 | - | ||||||
| Net decrease in cash and cash equivalents | (19,671 | ) | (863,796 | ) | ||||
| Cash and cash equivalents at beginning of period | 664,299 | 1,994,186 | ||||||
| Cash and cash equivalents at end of period | $ | 644,628 | $ | 1,130,390 | ||||
Source: